Skip to main content
SpringerLink
Log in
Book cover

Pädiatrische Hämatologie und Onkologie pp 441–464Cite as

Nierentumoren

  • Chapter

Part of the book series: Springer Reference Medizin ((SRM))

Zusammenfassung

Im Kindesalter ist das Nephroblastom der mit Abstand häufigste Nierentumor. Darüber hinaus können heute auch eine Vielzahl anderer kindlicher Nierentumoren unterschieden werden. Durch die kooperative Arbeit internationaler Therapieoptimierungsstudien konnte aus einem meist zum Tod führenden Tumor eine ganz überwiegend heilbare Erkrankung werden. Auch im Rezidiv werden mehr als die Hälfte der Patienten geheilt. Heute liegt das besondere Augenmerk der Behandlung neben der Verbesserung des Überlebens hochmaligner Nierentumoren vor allem auf der Verringerung der Spätfolgen und der weiteren Individualisierung entsprechend eines patientenspezifischen Risikoprofils.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Bergeron C, Iliescu C, Thiesse P et al. (2001) Does nephroblastomatosis influence the natural history and relapse rate in Wilms’ tumour? A single centre experience over 11 years. Eur J Cancer 37(3): 385–391

    Google Scholar 

  • Bissler JJ, Kingswood JC, Radzikowska E et al. (2013) Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 381(9869): 817–824

    Google Scholar 

  • Blakely ML, Shamberger RC, Norkool P et al. (2003) Outcome of children with cystic partially differentiated nephroblastoma treated with or without chemotherapy. J Pediatric Surg 38(6): 897–900

    Google Scholar 

  • Coppes MJ, Arnold M, Beckwith JB et al. (1999) Factors affecting the risk of contralateral Wilms tumor development: a report from the national Wilms tumor study group. Cancer 85(7): 1616–1625

    Google Scholar 

  • D’Angio GJ, Evans AE, Breslow N et al. (1976) The treatment of Wilms’ tumor: Results of the National Wilms’ Tumor Study. Cancer 38(2): 633–646

    Google Scholar 

  • D’Angio GJ, Evans A, Breslow N et al. (1981) The treatment of Wilms’ tumor: results of the Second National Wilms’ Tumor Study. Cancer 47(9): 2302–2311

    Google Scholar 

  • D’Angio GJ, Breslow N, Beckwith JB et al. (1989) Treatment of Wilms’ tumor results of the Third National Wilms’ Tumor Study. Cancer 64(2): 349–360

    Google Scholar 

  • De Camargo B, Franco EL (1994) A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of Wilms’ tumor Results after extended follow-up Brazilian Wilms’ Tumor Study Group. Cancer 73(12): 3081–3086

    Google Scholar 

  • De Kraker J, Lemerle J, Voute PA et al. (1990) Wilm’s tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. J Clin Oncol 8(7): 1187–1190

    Google Scholar 

  • Dome JS, Cotton CA, Perlman EJ et al. (2006) Treatment of anaplastic histology Wilms’ tumor: Results from the fifth National Wilms’ Tumor Study. J Clin Oncol 24(15): 2352–2358

    Google Scholar 

  • Fuchs J, Kienecker K, Furtwängler R et al. (2009) Surgical aspects in the treatment of patients with unilateral wilms tumor: a report from the SIOP 93–01/German society of pediatric oncology and hematology. Ann Surg 249(4): 666–671

    Google Scholar 

  • Furtwängler R, Reinhard H, Leuschner I et al. (2006) Mesoblastic nephroma – a report from the Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH). Cancer 106(10): 2275–2283

    Google Scholar 

  • Furtwängler R, Nourkami N, Alkassar M et al. (2011) Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies – a report from the GPOH-Nephroblastoma Study Group. Klin Pädiatrie 223(3): 113–119

    Google Scholar 

  • Furtwängler R, Gooskens SL, Van Tinteren H et al. (2013) Clear cell sarcomas of the kidney (CCSKs) registered on SIOP 93–01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. Eur J Cancer 49(16): 3497–3506

    Google Scholar 

  • Furtwängler R., Schmolze M, Gräber S et al. (2014a) Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma. Klin Pädiatrie 226(3): 175–181

    Google Scholar 

  • Furtwängler R, Nourkami-Tutdibi N, Leuschner I et al. (2014b) Malignant rhabdoid tumor of the kidney: Significantly improved response to pre-operative treatment intensified with doxorubicin. Cancer Genetics 207(9): 434–436

    Google Scholar 

  • Gooskens SLM, Furtwängler R, Vujanić GM et al. (2012) Clear cell sarcoma of the kidney: a review. Eur J Cancer 28: 2219–2226

    Google Scholar 

  • Gooskens SL, Furtwängler R, Spreafico F et al. (2014) Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study. Br J Cancer 111(2): 227–233

    Google Scholar 

  • Graf N, Van Tinteren H, Bergeron C et al. (2012) Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93–01. Eur J Cancer 48: 3240–3248

    Google Scholar 

  • Gratias EJ, Jennings LJ, Anderson JR et al. (2013) Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children’s Oncology Group. Cancer 119(21): 3887–3894

    Google Scholar 

  • Green DM (2004) The treatment of stages I–IV favorable histology Wilms’ tumor. J Clin Oncol 22(8): 1366–1372

    Google Scholar 

  • Green DM (2013) The evolution of treatment for Wilms tumor. J Pediatric Surg 48(1): 14–19

    Google Scholar 

  • Gross RE, Neuhauser EB (1950) Treatment of mixed tumors of the kidney in childhood. Pediatrics 6(6): 843–852

    Google Scholar 

  • Grundy PE, Breslow NE, Li S et al. (2005) Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23(29): 7312–7321

    Google Scholar 

  • Ha TC, Spreafico F, Graf N et al. (2012) An international strategy to determine the role of high dose therapy in recurrent Wilms’ tumor. Eur J Cancer 49: 194–210

    Google Scholar 

  • Jereb B, Tournade MF, Lemerle J et al. (1980) Lymph node invasion and prognosis in nephroblastoma. Cancer 45(7): 1632–1636

    Google Scholar 

  • Ladd WE (1938) Embryoma of the kidney (Wilms’ Tumor). Ann Surg 108(5): 885–902

    Google Scholar 

  • Lemerle J, Voute PA, Tournade MF et al. (1976) Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms’ tumor Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (SIOP). Cancer 38(2): 647–654

    Google Scholar 

  • Lemerle J, Voute PA, Tournade MF et al. (1983) Effectiveness of preoperative chemotherapy in Wilms’ tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol 1(10): 604–609

    Google Scholar 

  • Luithle T, Szavay P, Furtwängler R et al. (2007) Treatment of cystic nephroma and cystic partially differentiated nephroblastoma – a report from the SIOP/GPOH Study Group. J Urology 177(1): 294–296

    Google Scholar 

  • Metzger Ml, Stewart CF, Freeman BB 3rd et al. (2007) Topotecan is active against Wilms’ tumor: results of a multi-institutional phase II study. J Clin Oncol 25(21): 3130–3136

    Google Scholar 

  • Pein F, Sakiroglu O, Dahan M et al. (2004) Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer 91(1): 37–44

    Google Scholar 

  • Perlman EJ, Faria P, Soares A et al. (2006) Hyperplastic perilobar nephroblastomatosis: long-term survival of 52 patients. Pediatric Blood Cancer 46(2): 203–221

    Google Scholar 

  • Pritchard-Jones K, Kelsey A, Vujanić G et al. (2003) Older age is an adverse prognostic factor in stage I, favorable histology Wilms’ tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children’s Cancer Study Group, Wilm’s Tumor Working Group. J Clin Oncol 21(17): 3269–3275

    Google Scholar 

  • Pritchard-Jones K, Bergeron C, De Camargo B et al. (2015) Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms’ tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet 386(9999): 1156–1164

    Google Scholar 

  • Reinhard H, Semler O, Bürger D et al. (2004) Results of the SIOP 93–01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic wilms tumor. Klin Pädiatrie 216(3): 132–140

    Google Scholar 

  • Reinhard, H, Reinert, J, Beier, R et al. (2008) Rhabdoid tumors in children: Prognostic factors in 70 patients diagnosed in Germany. Oncol Reports 19(3): 819–823

    Google Scholar 

  • Royer-Pokora B (2013) Genetics of pediatric renal tumors. Pediatric Nephrol 28(1): 13–23

    Google Scholar 

  • Schenk J, Schrader C, Zieger B et al. (2006) Reference radiology in nephroblastoma: accuracy and relevance for preoperative chemotherapy. Rö Fo 178(1): 38–45

    Google Scholar 

  • Selle B, Furtwängler R, Graf N et al. (2006) Population-based study of renal cell carcinoma in children in Germany, 1980–2005: More frequently localized tumors and underlying disorders compared with adult counterparts. Cancer 107(12): 2906–2914

    Google Scholar 

  • Tournade MF, Com-Nougué C, Voute PA et al. (1993) Results of the Sixth International Society of Pediatric Oncology Wilms’ Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms’ tumor. J Clin Oncol 11(6): 1014–1023

    Google Scholar 

  • Tournade MF, Com-Nougué C, De Kraker J et al. (2001) Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms’ tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms’ Tumor Trial and Study. J Clin Oncol 19(2): 488–500

    Google Scholar 

  • Van den Heuvel-Eibrink MM, Van Tinteren H, Rehors H et al. (2011) Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group. Pediatric Blood Cancer 56(5): 733–737

    Google Scholar 

  • Van den Heuvel-Eibrink MM, van Tinteren H, Bergeron C et al. (2015) Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). Eur J Cancer 51(4): 498–506

    Google Scholar 

  • Verschuur AC, Vujanić GM, Van Tinteren H et al. (2010) Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93–01 experience. Pediatric Blood Cancer 55(2): 233–238

    Google Scholar 

  • Verschuur A, Van Tinteren H, Graf N et al. (2012) Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy. J Clin Oncol 30(28): 3533–3539

    Google Scholar 

  • Vokuhl C, Vogelgesang W, Leuschner I et al. (2014) 1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk stratification in the SIOP2001/GPOH trial. Genes Chromosomes Cancer 53(11): 960–962

    Google Scholar 

  • Vujanić GM, Harms D, Sandstedt B et al. (1999) New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience. Med Pediatric Oncol 32(5): 317–323

    Google Scholar 

  • Vujanić GM, Sandstedt B, Harms D et al. (2002) Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatric Oncol 38(2): 79–82

    Google Scholar 

  • Vujanić GM, Kelsey A, Mitchel, C, Shannon RS, Gornall P (2003) The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms tumor study 3. Med Ped Oncol 40(1): 18–22

    Google Scholar 

  • Warmann SW, Furtwängler R, Blumenstock G et al. (2011) Tumor biology influences the prognosis of nephroblastoma patients with primary pulmonary metastases: Results from SIOP 93–01/GPOH and SIOP 2001/GPOH. Ann Surg 254(1): 155–162

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik f Pädiatrische Onkologie u Hämatologie, Universitätsklinikum des Saarlandes, Gebäude 9, 66421, Homburg/Saar, Deutschland

    Dr. med. R. Furtwängler & Prof. Dr. med. N. Graf

Authors
  1. Dr. med. R. Furtwängler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. N. Graf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to R. Furtwängler or N. Graf .

Editor information

Editors and Affiliations

  1. Universitätsklinik um Freiburg Zentrum für Kinder- und Jugendmedizin, Freiburg, Deutschland

    Charlotte Niemeyer

  2. Charité-Universitätsmedizin Berlin, Berlin, Deutschland

    Angelika Eggert

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Furtwängler, R., Graf, N. (2018). Nierentumoren. In: Niemeyer, C., Eggert, A. (eds) Pädiatrische Hämatologie und Onkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43686-8_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-43686-8_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43685-1

  • Online ISBN: 978-3-662-43686-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation